Quantum-Si sequences first customer samples on Proteus platform in major milestone

Quantum-Si sequences first customer samples on Proteus platform in major milestone
Quantum-Si sequences customer samples

Quantum-Si has sequenced its first customer samples using the Proteus platform, signaling a pivotal achievement for the company.

The move is expected to advance the adoption of next-generation protein sequencing technologies, as the firm brings Proteus closer to commercial maturity. Quantum-Si announced the update via a company press release, underlining its focus on accelerating breakthroughs in proteomics. Proteus is positioned to reshape the protein analysis market by providing researchers and laboratories with advanced sequencing capabilities that could improve biomarker discovery and clinical research.

Quantum-Si previously introduced single molecule sequencing to improve detection of post-translational modifications in protein analysis workflows, according to a past company announcement. The firm has also unveiled a platform capable of sequencing proteins from nanogram-scale samples with single-amino-acid resolution, as detailed in an earlier product update. These developments have set the stage for the firm's broader push into next-generation proteomics.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.